← Back to Search

Procedure

CB-CT Imaging for Stroke

Q: Are geriatric patients eligible for the current research project?

<p>Per the trial's requirements, eligible participants must be between 18 to 99 years of age. There are seven separate trials for minors and 335 more specifically targeting seniors.</p>

Q: To what extent are participants engaging in this research endeavor?

<p>Affirmative. Per clinicaltrials.gov, the research project first posted on January 1st 2023 is actively recruiting participants for their study; 90 people are needed from one location. The information was recently updated on September 8th 2022.</p>

N/A

Waitlist Available

Led By Beverly Aagaard-Kienitz, MD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 visit (up to 120 minutes)

Awards & highlights

Study Summary

This trial is testing whether using a cone beam computed tomography (CB-CT) machine for both imaging and reconstruction can save time for acute ischemic stroke patients.

Who is the study for?

This trial is for adults over 18 with a recent ischemic stroke within the last 24 hours, who have a blockage in a large artery and are not severely ill with other conditions. They must have an NIHSS score of less than 8, indicating mild to moderate stroke severity, and cannot be pregnant or have severe kidney disease.Check my eligibility

What is being tested?

The study is testing if using C-arm Cone Beam Computed Tomography (CB-CT) can save substantial time during cerebrovascular interventions by quickly acquiring and reconstructing images for acute ischemic stroke patients compared to standard Multi-detector CT.See study design

What are the potential side effects?

While the trial focuses on imaging techniques rather than medications, potential side effects may include discomfort from remaining still during imaging, exposure to radiation, and risks associated with contrast agents used such as allergic reactions or kidney issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 visit (up to 120 minutes)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 visit (up to 120 minutes)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 visit (up to 120 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility measured as the amount of time from hospital arrival to the angiography suite

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: C-ARM CBCTExperimental Treatment1 Intervention

A C-arm CBCT evaluation with SMART RECON novel software for the rapid assessment of time-resolved CT angiogram and CT perfusion.

Group II: MD-CTActive Control1 Intervention

An evaluation with conventional, standard of care, multi-detector CT (MD-CT)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

C-Arm Cone Beam Computed Tomography

2017

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,182 Previous Clinical Trials

3,167,297 Total Patients Enrolled

14 Trials studying Stroke

271,120 Patients Enrolled for Stroke

National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH

89 Previous Clinical Trials

19,694 Total Patients Enrolled

Beverly Aagaard-Kienitz, MDPrincipal InvestigatorUniversity of Wisconsin, Madison

1 Previous Clinical Trials

60 Total Patients Enrolled

Media Library

C-arm Cone Beam CTP Guided Cerebrovascular Interventions (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05536895 — N/A

Stroke Research Study Groups: C-ARM CBCT, MD-CT

Stroke Clinical Trial 2023: C-arm Cone Beam CTP Guided Cerebrovascular Interventions Highlights & Side Effects. Trial Name: NCT05536895 — N/A

C-arm Cone Beam CTP Guided Cerebrovascular Interventions (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05536895 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being recruited for this experimentation?

"Data hosted on clinicaltrials.gov shows that this medical experiment is in the process of enrolling participants, and initially appeared online on January 1st 2023 with a recent update occurring September 8th 2022."

Answered by AI

What are the eligibility criteria to participate in this research?

"This research project is expecting 90 qualified individuals between 18 and 99 who have experienced a cerebrovascular mishap. To be accepted, they must meet all of the following conditions: acute stroke in the 24 hours before admission, an artery occlusion that's substantial enough to qualify, no more severe co-morbidities than National Institutes of Health Stroke Scale (NIHSS) < 8 score and those potentially able to bear children can not be pregnant."

Answered by AI

Are geriatric patients eligible for the current research project?

"Per the trial's requirements, eligible participants must be between 18 to 99 years of age. There are seven separate trials for minors and 335 more specifically targeting seniors."

Answered by AI

To what extent are participants engaging in this research endeavor?

"Affirmative. Per clinicaltrials.gov, the research project first posted on January 1st 2023 is actively recruiting participants for their study; 90 people are needed from one location. The information was recently updated on September 8th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

C-arm Cone Beam CTP Guided Cerebrovascular Interventions

2024. "C-arm Cone Beam CTP Guided Cerebrovascular Interventions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05536895.